139 related articles for article (PubMed ID: 34419687)
1. Serum fibroblast growth factor 21 and growth differentiation factor 15: Two sensitive biomarkers in the diagnosis of mitochondrial disorders.
Huddar A; Govindaraj P; Chiplunkar S; Deepha S; Jessiena Ponmalar JN; Philip M; Nagappa M; Narayanappa G; Mahadevan A; Sinha S; Taly AB; Parayil Sankaran B
Mitochondrion; 2021 Sep; 60():170-177. PubMed ID: 34419687
[TBL] [Abstract][Full Text] [Related]
2. GDF-15 Is Elevated in Children with Mitochondrial Diseases and Is Induced by Mitochondrial Dysfunction.
Montero R; Yubero D; Villarroya J; Henares D; Jou C; Rodríguez MA; Ramos F; Nascimento A; Ortez CI; Campistol J; Perez-Dueñas B; O'Callaghan M; Pineda M; Garcia-Cazorla A; Oferil JC; Montoya J; Ruiz-Pesini E; Emperador S; Meznaric M; Campderros L; Kalko SG; Villarroya F; Artuch R; Jimenez-Mallebrera C
PLoS One; 2016; 11(2):e0148709. PubMed ID: 26867126
[TBL] [Abstract][Full Text] [Related]
3. Growth differentiation factor 15 as a useful biomarker for mitochondrial disorders.
Yatsuga S; Fujita Y; Ishii A; Fukumoto Y; Arahata H; Kakuma T; Kojima T; Ito M; Tanaka M; Saiki R; Koga Y
Ann Neurol; 2015 Nov; 78(5):814-23. PubMed ID: 26463265
[TBL] [Abstract][Full Text] [Related]
4. The Mitochondrial Biomarkers FGF-21 and GDF-15 in Patients with Episodic and Chronic Migraine.
Burow P; Haselier M; Naegel S; Scholle LM; Gaul C; Kraya T
Cells; 2021 Sep; 10(9):. PubMed ID: 34572118
[TBL] [Abstract][Full Text] [Related]
5. A comparison of current serum biomarkers as diagnostic indicators of mitochondrial diseases.
Davis RL; Liang C; Sue CM
Neurology; 2016 May; 86(21):2010-5. PubMed ID: 27164684
[TBL] [Abstract][Full Text] [Related]
6. Plasma FGF-21 and GDF-15 are elevated in different inherited metabolic diseases and are not diagnostic for mitochondrial disorders.
Tsygankova PG; Itkis YS; Krylova TD; Kurkina MV; Bychkov IO; Ilyushkina AA; Zabnenkova VV; Mikhaylova SV; Pechatnikova NL; Sheremet NL; Zakharova EY
J Inherit Metab Dis; 2019 Sep; 42(5):918-933. PubMed ID: 31260105
[TBL] [Abstract][Full Text] [Related]
7. FGF-21 as a biomarker for muscle-manifesting mitochondrial respiratory chain deficiencies: a diagnostic study.
Suomalainen A; Elo JM; Pietiläinen KH; Hakonen AH; Sevastianova K; Korpela M; Isohanni P; Marjavaara SK; Tyni T; Kiuru-Enari S; Pihko H; Darin N; Õunap K; Kluijtmans LA; Paetau A; Buzkova J; Bindoff LA; Annunen-Rasila J; Uusimaa J; Rissanen A; Yki-Järvinen H; Hirano M; Tulinius M; Smeitink J; Tyynismaa H
Lancet Neurol; 2011 Sep; 10(9):806-18. PubMed ID: 21820356
[TBL] [Abstract][Full Text] [Related]
8. Plasma Gelsolin Reinforces the Diagnostic Value of FGF-21 and GDF-15 for Mitochondrial Disorders.
Peñas A; Fernández-De la Torre M; Laine-Menéndez S; Lora D; Illescas M; García-Bartolomé A; Morales-Conejo M; Arenas J; Martín MA; Morán M; Domínguez-González C; Ugalde C
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34203775
[TBL] [Abstract][Full Text] [Related]
9. FGF-21 as a Potential Biomarker for Mitochondrial Diseases.
Scholle LM; Lehmann D; Deschauer M; Kraya T; Zierz S
Curr Med Chem; 2018; 25(18):2070-2081. PubMed ID: 29332568
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic value of serum biomarkers FGF21 and GDF15 compared to muscle sample in mitochondrial disease.
Lehtonen JM; Auranen M; Darin N; Sofou K; Bindoff L; Hikmat O; Uusimaa J; Vieira P; Tulinius M; Lönnqvist T; de Coo IF; Suomalainen A; Isohanni P
J Inherit Metab Dis; 2021 Mar; 44(2):469-480. PubMed ID: 32857451
[TBL] [Abstract][Full Text] [Related]
11. Growth Differentiation Factor 15 is a potential biomarker of therapeutic response for TK2 deficient myopathy.
Dominguez-Gonzalez C; Badosa C; Madruga-Garrido M; Martí I; Paradas C; Ortez C; Diaz-Manera J; Berardo A; Alonso-Pérez J; Trifunov S; Cuadras D; Kalko SG; Blázquez-Bermejo C; Cámara Y; Martí R; Mavillard F; Martin MA; Montoya J; Ruiz-Pesini E; Villarroya J; Montero R; Villarroya F; Artuch R; Hirano M; Nascimento A; Jimenez-Mallebrera C
Sci Rep; 2020 Jun; 10(1):10111. PubMed ID: 32572108
[TBL] [Abstract][Full Text] [Related]
12. Accuracy of FGF-21 and GDF-15 for the diagnosis of mitochondrial disorders: A meta-analysis.
Lin Y; Ji K; Ma X; Liu S; Li W; Zhao Y; Yan C
Ann Clin Transl Neurol; 2020 Jul; 7(7):1204-1213. PubMed ID: 32585080
[TBL] [Abstract][Full Text] [Related]
13. GDF-15, a mitochondrial disease biomarker, is associated with the severity of multiple sclerosis.
Nohara S; Ishii A; Yamamoto F; Yanagiha K; Moriyama T; Tozaka N; Miyake Z; Yatsuga S; Koga Y; Hosaka T; Terada M; Yamaguchi T; Aizawa S; Mamada N; Tsuji H; Tomidokoro Y; Nakamagoe K; Ishii K; Watanabe M; Tamaoka A
J Neurol Sci; 2019 Oct; 405():116429. PubMed ID: 31476622
[TBL] [Abstract][Full Text] [Related]
14. Mitochondrial metabolism related markers GDF-15, FGF-21, and HIF-1α are elevated in pediatric migraine attacks.
Kilinc YB; Kilinc E; Danis A; Hanci F; Turay S; Ozge A; Bolay H
Headache; 2023 Sep; 63(8):1076-1086. PubMed ID: 37596867
[TBL] [Abstract][Full Text] [Related]
15. Oxidative Phosphorylation Dysfunction Modifies the Cell Secretome.
Garrido-Pérez N; Vela-Sebastián A; López-Gallardo E; Emperador S; Iglesias E; Meade P; Jiménez-Mallebrera C; Montoya J; Bayona-Bafaluy MP; Ruiz-Pesini E
Int J Mol Sci; 2020 May; 21(9):. PubMed ID: 32397676
[TBL] [Abstract][Full Text] [Related]
16. FGF21 outperforms GDF15 as a diagnostic biomarker of mitochondrial disease in children.
Riley LG; Nafisinia M; Menezes MJ; Nambiar R; Williams A; Barnes EH; Selvanathan A; Lichkus K; Bratkovic D; Yaplito-Lee J; Bhattacharya K; Ellaway C; Kava M; Balasubramaniam S; Christodoulou J
Mol Genet Metab; 2022 Jan; 135(1):63-71. PubMed ID: 34991945
[TBL] [Abstract][Full Text] [Related]
17. Growth Differentiation Factor 15 Is a Novel Diagnostic Biomarker of Mitochondrial Diseases.
Ji X; Zhao L; Ji K; Zhao Y; Li W; Zhang R; Hou Y; Lu J; Yan C
Mol Neurobiol; 2017 Dec; 54(10):8110-8116. PubMed ID: 27889897
[TBL] [Abstract][Full Text] [Related]
18. FGF21 is a biomarker for mitochondrial translation and mtDNA maintenance disorders.
Lehtonen JM; Forsström S; Bottani E; Viscomi C; Baris OR; Isoniemi H; Höckerstedt K; Österlund P; Hurme M; Jylhävä J; Leppä S; Markkula R; Heliö T; Mombelli G; Uusimaa J; Laaksonen R; Laaksovirta H; Auranen M; Zeviani M; Smeitink J; Wiesner RJ; Nakada K; Isohanni P; Suomalainen A
Neurology; 2016 Nov; 87(22):2290-2299. PubMed ID: 27794108
[TBL] [Abstract][Full Text] [Related]
19. Associations of FGF21 and GDF15 with mitochondrial dysfunction in children living with perinatally-acquired HIV: A cross-sectional evaluation of pediatric AIDS clinical trials group 219/219C.
Gojanovich GS; Jacobson DL; Broadwell C; Karalius B; Kirmse B; Geffner ME; Jao J; Van Dyke RB; McFarland EJ; Silio M; Crain M; Gerschenson M;
PLoS One; 2021; 16(12):e0261563. PubMed ID: 34972147
[TBL] [Abstract][Full Text] [Related]
20. Association of fibroblast growth factor (FGF-21) as a biomarker with primary mitochondrial disorders, but not with secondary mitochondrial disorders (Friedreich Ataxia).
Salehi MH; Kamalidehghan B; Houshmand M; Aryani O; Sadeghizadeh M; Mossalaeie MM
Mol Biol Rep; 2013 Nov; 40(11):6495-9. PubMed ID: 24078096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
